TY - JOUR T1 - In patients with localised prostate cancer, active surveillance is associated with better sexual function, urinary symptoms and bowel symptoms JF - Evidence Based Medicine JO - Evid Based Med SP - 217 LP - 218 DO - 10.1136/ebmed-2017-110759 VL - 22 IS - 6 AU - Roderick C N van den Bergh AU - Marie-Anne van Stam Y1 - 2017/12/01 UR - http://ebm.bmj.com/content/22/6/217.abstract N2 - Commentary on: Chen RC, Basak R, Meyer AM, et al. Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localised prostate cancer. JAMA 2017;317:1141–50.Many patients with prostate cancer are diagnosed with low-risk disease only, for whom the benefit of surgery or radiation on life expectancy may be very limited, while still bringing the risk of side effects.1 2 Therefore, patients with low-risk prostate cancer are currently offered the option of active surveillance. This strategy delays therapy with curative intent until progression occurs, or it may completely avoid radical treatment.3 As a result, in the treatment decision-making process of patients newly diagnosed with prostate cancer, up-to-date and preferably personalised information about the possible positive and negative effects of the treatment options is vital.Chen and colleagues conducted a US population-based, observational study on 1141 men diagnosed with mostly … ER -